GEER R. J. ET AL.: "Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome", ANNALS OF SURGERY, vol. 212, no. 6, 1990, pages 678 - 687, XP055482097 (B1)

LUDOVICA FS GRASSO ET AL: "Investigational therapies for acromegaly", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 22, no. 8, 3 June 2013 (2013-06-03), UK, pages 955 - 963, XP055511392, ISSN: 1354-3784, DOI: 10.1517/13543784.2013.805201 (B1)

LUSTIG R. H. ET AL.: "A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion", INTERNATIONAL JOURNAL OF OBESITY, vol. 30, no. 2, 2006, pages 331 - 341, XP055482103 (B1)

WO-A1-87/07149 (B1)

S. TUVIA ET AL: "Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 97, no. 7, 1 July 2012 (2012-07-01), US, pages 2362 - 2369, XP055511343, ISSN: 0021-972X, DOI: 10.1210/jc.2012-1179 (B1)

US-A1- 2010 105 627 (B1)

US-A1- 2010 151 033 (B1)

MELMED S ET AL: "OR17-5: Efficacy and Safety of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial in 155 Patients", 22 June 2014 (2014-06-22), & 96TH ANNUAL MEETING AND EXPO OF THE ENDOCRINE-SOCIETY; CHICAGO, IL, USA; JUNE 21 -24, 2014, XP002785262, Retrieved from the Internet <URL:http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2014.NP.7.OR17-5> [retrieved on 20170928] (B1)